Analysis of Delayed Surgical Treatment and Oncologic Outcomes in Clinical Stage I Non-Small Cell Lung Cancer - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34042991/
Using a more precise definition for TTS, this study found that surgical procedures delayed more than 12 weeks were associated with increased risk of recurrence and worse survival. These findings...
-
Naveed Saleh, MD, MS – Skipta Team5yrKey Points • In the current retrospective study, researchers employed a uniform method to assess surgical treatment delay and its associated outcomes in 9904 patients who underwent surgical treatment for clinical Show More
Multi-channel multi-task deep learning for predicting EGFR and KRAS mutations of non-small cell lung cancer on CT images - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34079707/
1 School of Software, Taiyuan University of Technology, Taiyuan, China. 2 School of Information and Computer, Taiyuan University of Technology, Taiyuan, China. 3 Department of Radiology, Shanxi Province Cancer Hospital,...
-
Naveed Saleh, MD, MS – Skipta Team5yrKey Points • As a means to provide targeted therapy, the prediction of the mutation status of EGFR and KRAS in NSCLC is useful. After all, CT is cost-effective and non-invasive. Show More
Polymorphisms in EGFR Gene Predict Clinical Outcome in Unresectable Non-Small Cell Lung Cancer Treated with Radiotherapy and Platinum-Based Chemoradiotherapy - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34070597/
For non-small cell lung cancer (NSCLC), radiotherapy (RT) and platinum-based chemotherapy (CHT) are among the main treatment options. On the other hand, radioresistance and cytotoxic drug resistance are common causes...
Protein Kinase C as a Therapeutic Target in Non-Small Cell Lung Cancer - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34073823/
1 Department of Biochemistry, Molecular and Cellular Biology, Stony Brook University, Stony Brook, NY 11794, USA. 2 Stony Brook Cancer Center, Stony Brook University Hospital, Stony Brook, NY 11794, USA....
CRKL is a critical target of Hh-GLI2 pathway in lung adenocarcinoma - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34076957/
Lung adenocarcinoma (LUAD) is one of the important components of non-small-cell lung cancer (NSCLC) and leads to many deaths every year. During the initiation and progression of the LUAD, the...